BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF), a pioneer in Botanical Synthesis technology, has announced its participation in the LD Micro Main Event XVII Conference on October 30, 2024. CEO Ilan Sobel will host one-on-one meetings with institutional investors and deliver a virtual presentation at 3:00 p.m. Eastern time.
Sobel expressed enthusiasm for the event, highlighting the company's recent Q2 financial results showing steady growth in both their high-margin Products business unit and the newly launched CDMO Services business unit. He also mentioned plans to introduce new products in Q4 2024 and the company's goal of achieving a Nasdaq listing by the end of the year.
Interested parties can join the online presentation via the provided webcast link. For more information or to schedule a meeting with management, contact MZ Group at BHSC@mzgroup.us.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF), un pioniere nella tecnologia della Sintesi Botanica, ha annunciato la sua partecipazione alla LD Micro Main Event XVII Conference il 30 ottobre 2024. Il CEO Ilan Sobel ospiterà incontri individuali con investitori istituzionali e presenterà una presentazione virtuale alle 15:00 ora orientale.
Sobel ha espresso entusiasmo per l'evento, sottolineando i recenti risultati finanziari del secondo trimestre, che mostrano una crescita costante sia nella loro unità di business ad alto margine sui Prodotti sia nella nuova unità di business dei Servizi CDMO. Ha anche menzionato i piani di introdurre nuovi prodotti nel quarto trimestre del 2024 e l'obiettivo dell'azienda di ottenere una quotazione al Nasdaq entro la fine dell'anno.
Le parti interessate possono partecipare alla presentazione online tramite il link fornito per il webcast. Per ulteriori informazioni o per pianificare un incontro con il management, contattare il MZ Group all'indirizzo BHSC@mzgroup.us.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF), un pionero en tecnología de Síntesis Botánica, ha anunciado su participación en la LD Micro Main Event XVII Conference el 30 de octubre de 2024. El CEO Ilan Sobel llevará a cabo reuniones individuales con inversores institucionales y presentará una exposición virtual a las 3:00 p.m. hora del este.
Sobel expresó entusiasmo por el evento, destacando los recientes resultados financieros del segundo trimestre, que muestran un crecimiento constante tanto en su unidad de negocio de Productos de alto margen como en la recién lanzada unidad de Servicios CDMO. También mencionó planes para introducir nuevos productos en el cuarto trimestre de 2024 y el objetivo de la empresa de lograr una cotización en Nasdaq para finales de año.
Las partes interesadas pueden unirse a la presentación en línea a través del enlace proporcionado para el webcast. Para más información o para programar una reunión con la dirección, contactar al MZ Group en BHSC@mzgroup.us.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF)는 식물 합성 기술의 선두주자로서 LD Micro Main Event XVII Conference에 2024년 10월 30일 참석한다고 발표했습니다. CEO Ilan Sobel는 기관 투자자들과의 일대일 회의를 주관하고 동부 표준시 기준으로 오후 3시에 가상 프리젠테이션을 진행할 예정입니다.
Sobel은 이번 행사에 대한 기대감을 표명하며, 최근의 2분기 재무 결과가 고수익 제품 비즈니스 단위와 새로 출시된 CDMO 서비스 비즈니스 단위 모두에서 지속적인 성장을 보여준 점을 강조했습니다. 그는 또한 2024년 4분기에 새로운 제품을 출시할 계획과 연말까지 나스닥 상장을 목표로 하고 있다고 언급했습니다.
관심 있는 분들은 제공된 웹캐스트 링크를 통해 온라인 프리젠테이션에 참여할 수 있습니다. 더 많은 정보나 경영진과 회의를 예약하고 싶으신 분은 MZ Group을 통해 BHSC@mzgroup.us로 연락해 주시기 바랍니다.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF), un pionnier dans la technologie de Synthèse Botanique, a annoncé sa participation à la LD Micro Main Event XVII Conference le 30 octobre 2024. Le PDG Ilan Sobel organisera des réunions individuelles avec des investisseurs institutionnels et présentera une exposition virtuelle à 15h00 heure de l'Est.
Sobel a exprimé son enthousiasme pour l'événement, soulignant les récents résultats financiers du deuxième trimestre qui montrent une croissance constante tant dans leur unité d'affaires à forte marge que dans la nouvelle unité de services CDMO. Il a également mentionné des projets pour introduire de nouveaux produits au quatrième trimestre de 2024 et l'objectif de l'entreprise d'obtenir une cotation au Nasdaq d'ici la fin de l'année.
Les personnes intéressées peuvent rejoindre la présentation en ligne via le lien de webcast fourni. Pour plus d'informations ou pour planifier une réunion avec la direction, veuillez contacter MZ Group à l'adresse BHSC@mzgroup.us.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF), ein Pionier in der Botanischen Synthesetechnologie, hat seine Teilnahme an der LD Micro Main Event XVII Conference am 30. Oktober 2024 angekündigt. CEO Ilan Sobel wird Einzelgespräche mit institutionellen Investoren führen und um 15:00 Uhr Eastern Time eine virtuelle Präsentation halten.
Sobel äußerte sich begeistert über die Veranstaltung und hob die jüngsten Q2-Finanzergebnisse hervor, die ein stetiges Wachstum sowohl in ihrer margenstarken Produktgeschäftseinheit als auch in der neu gegründeten CDMO-Dienstleistungsabteilung zeigen. Er erwähnte auch Pläne, im 4. Quartal 2024 neue Produkte einzuführen, sowie das Ziel des Unternehmens, bis zum Jahresende eine Nasdaq-Listung zu erreichen.
Interessierte können über den bereitgestellten Webcast-Link an der Online-Präsentation teilnehmen. Für weitere Informationen oder zur Vereinbarung eines Treffens mit dem Management wenden Sie sich bitte an die MZ Group unter BHSC@mzgroup.us.
- None.
- None.
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 16, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology process, today announced that management has been invited to attend the LD Micro Main Event XVII Conference taking place on October 30, 2024.
CEO Ilan Sobel is scheduled to host one-on-one meetings with institutional investors throughout the event, and will host a virtual presentation as follows:
LD Micro Main Event XVII Conference
Date: Wednesday, October 30, 2024
Location: Luxe Sunset Boulevard Hotel - Los Angeles, CA
Time: 3:00 p.m. Eastern time
Webcast: https://me24.sequireevents.com/
All interested media and investors are invited to join this online presentation. Please join at least five minutes before the start of the presentation to ensure timely participation.
Sobel stated: "I look forward to a day of productive meetings with institutional investors at the LD Micro Main Event. As reported in our recent Q2 financials, the steady growth we continue to see is incredibly encouraging, in both our high-margin Products business unit, and in the recently launched CDMO Services business unit.
"We have also announced that we expect to introduce new products in Q4 2024, which will position us to continue our cadence of operational execution as we move closer to a targeted Nasdaq listing by the end of this year," concluded Sobel.
A live audio webcast and archive of the presentation will be available using the webcast link above. Registration is mandatory for conference participation. For more information or to schedule a meeting with management, please contact MZ Group at BHSC@mzgroup.us.
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV0) is a leader in Botanical Synthesis, leveraging its patented technology platform to grow plant-based molecules, without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit www.bioharvest.com.
Forward-Looking Statements
Information set forth in this news release might include forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.
Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy or accuracy of this release.
This release has been reviewed and approved by Dave Ryan, VP Investor Relations, who accepts responsibilities for its contents.
BioHarvest Corporate Contact:
Dave Ryan, VP Investor Relations
+1 (604) 622-1186
info@bioharvest.com
Investor Relations Contact:
Lucas A. Zimmerman
Managing Director
MZ Group - MZ North America
+1 (949) 259-4987
BHSC@mzgroup.us
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/226796
FAQ
When is BioHarvest Sciences (CNVCF) participating in the LD Micro Main Event XVII Conference?
What time is BioHarvest Sciences' (CNVCF) presentation at the LD Micro Main Event XVII Conference?
Where can I watch BioHarvest Sciences' (CNVCF) presentation at the LD Micro Main Event XVII Conference?
What growth areas did BioHarvest Sciences (CNVCF) highlight in their recent Q2 financials?
When does BioHarvest Sciences (CNVCF) plan to introduce new products?
What is BioHarvest Sciences' (CNVCF) target for Nasdaq listing?
